Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation
低强度异基因造血细胞移植后雷帕霉素耐药供体 CD4+ Th2/Th1(T-Rapa)细胞的 2 期临床试验
期刊:Blood
影响因子:21
doi:10.1182/blood-2012-08-446872
Daniel H Fowler, Miriam E Mossoba, Seth M Steinberg, David C Halverson, David Stroncek, Hahn M Khuu, Frances T Hakim, Luciano Castiello, Marianna Sabatino, Susan F Leitman, Jacopo Mariotti, Juan C Gea-Banacloche, Claude Sportes, Nancy M Hardy, Dennis D Hickstein, Steven Z Pavletic, Scott Rowley, And